The role of IL-10 in promoting disease progression in leishmaniasis

被引:390
作者
Kane, MM [1 ]
Mosser, DM [1 ]
机构
[1] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA
关键词
D O I
10.4049/jimmunol.166.2.1141
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the role of IL-10 in cutaneous leishmaniasis, we examined lesion development following Leishmania major infection of genetically susceptible BALB/c mice lacking IL-10. Whereas normal BALB/c mice developed progressive nonhealing lesions with numerous parasites within them, IL-10(-/-) BALB/c mice controlled disease progression, and had relatively small lesions with 1000-fold fewer parasites within them by the fifth week of infection. We also examined a mechanism whereby Leishmania induced the production of IL-10 from macrophages. We show that surface IgG on Leishmania amastigotes allows them to ligate Fc gamma receptors on inflammatory macrophages to preferentially induce the production of high amounts of IL-10, The IL-10 produced by infected macrophages prevented macrophage activation and diminished their production of IL-12 and TNF-alpha. In vitro survival assays confirmed the importance of IL-10 in preventing parasite killing by activated macrophages. Pretreatment of monolayers with either rIL-10 or supernatants from amastigote-infected macrophages resulted in a dramatic enhancement in parasite intracellular survival. These studies indicate that amastigotes of Leishmania use an unusual and unexpected virulence factor, host IgG. This IgG allows amastigotes to exploit the antiinflammatory effects of Fc gammaR ligation to induce the production of IL-10, which renders macrophages refractory to the activating effects of IFN-gamma.
引用
收藏
页码:1141 / 1147
页数:7
相关论文
共 31 条
  • [1] IMMUNE-RESPONSES ASSOCIATED WITH SUSCEPTIBILITY OF C57BL/10 MICE TO LEISHMANIA-AMAZONENSIS
    AFONSO, LCC
    SCOTT, P
    [J]. INFECTION AND IMMUNITY, 1993, 61 (07) : 2952 - 2959
  • [2] Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes
    Berger, S
    Chandra, R
    Ballo, H
    Hildenbrand, R
    Stutte, HJ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (11) : 2994 - 3000
  • [3] Experimental Leishmania major infection in mice:: role of IL-10
    Chatelain, R
    Mauze, S
    Coffman, RL
    [J]. PARASITE IMMUNOLOGY, 1999, 21 (04) : 211 - 218
  • [4] ELON J, 1992, ISRAEL J MED SCI, V28, P847
  • [5] Gasim S, 1998, CLIN EXP IMMUNOL, V111, P64
  • [6] INTERLEUKIN-10 PRODUCTION CORRELATES WITH PATHOLOGY IN HUMAN LEISHMANIA-DONOVANI INFECTIONS
    GHALIB, HW
    PIUVEZAM, MR
    SKEIKY, YAW
    SIDDIG, M
    HASHIM, FA
    ELHASSAN, AM
    RUSSO, DM
    REED, SG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) : 324 - 329
  • [7] GREEN SJ, 1990, J IMMUNOL, V144, P278
  • [8] Groux H, 1999, J IMMUNOL, V162, P1723
  • [9] COMPARISON OF RECEPTORS REQUIRED FOR ENTRY OF LEISHMANIA-MAJOR AMASTIGOTES INTO MACROPHAGES
    GUY, RA
    BELOSEVIC, M
    [J]. INFECTION AND IMMUNITY, 1993, 61 (04) : 1553 - 1558
  • [10] Altered immune responses in interleukin 10 transgenic mice
    Hagenbaugh, A
    Sharma, S
    Dubinett, SM
    Wei, SHY
    Aranda, R
    Cheroutre, H
    Fowell, DJ
    Binder, S
    Tsao, B
    Locksley, RM
    Moore, KW
    Kronenberg, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (12) : 2101 - 2110